Health Canada Requests Safety Data Profiles For ADHD Stimulant Drugs
Health Canada requests that manufacturers of stimulants to treat attention deficit/hyperactivity disorder submit "thorough" safety data reviews following the suspension of sales in Canada of Shire's Adderall XR